s the world’s largest healthcare company, we are driven to foster better health for more people in more places around the world.
While the world has made significant progress in providing improved healthcare, major gaps remain. Exacerbated by the COVID-19 pandemic, bolder, smarter approaches are needed to overcome the drastic inequity in access to care—now more than ever.
Through a dedicated global public health (GPH) organization that combines world-class research and development, global strategy and external affairs capabilities, and local implementation and impact teams, we put the world’s most underserved at the heart of everything we do—measuring our success in lives improved.
As a team of innovators, we are committed to pioneering and sustainably delivering meaningful and transformational products in areas where we believe we can make a profound difference: from expanding access to care in HIV, Tuberculosis and global mental health to addressing & preventing future pandemics. Working with global and local partners, we ensure the critical solutions necessary are within reach of those who need them to save lives, cure patients and prevent disease.
Upholding the rich heritage of Johnson & Johnson, we are taking on the toughest challenges, and, ultimately, we will do our part to close the gap of inequity and pave the way to a healthier future where all people and communities can thrive.
Johnson & Johnson has a long history of developing innovative medicines and technologies, and we continue to strengthen our R&D pipeline to turn science into solutions for the world’s most vulnerable communities.
Johnson & Johnson's Global Public Health unit is a model in the industry on access planning and results for several therapeutic areas, and it's constantly challenging itself to do more.